
Results
9
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
9 companies
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 238.10
7D
0.5%
1Y
-41.9%
Genmab
Market Cap: DKK 110.7b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,802.50
7D
2.5%
1Y
48.1%
ALK-Abelló
Market Cap: DKK 46.0b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 207.60
7D
0.9%
1Y
51.1%
H. Lundbeck
Market Cap: DKK 38.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 39.84
7D
-2.3%
1Y
41.7%
Zealand Pharma
Market Cap: DKK 21.0b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 296.80
7D
-0.4%
1Y
-30.8%
Bavarian Nordic
Market Cap: DKK 15.0b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 194.60
7D
-0.6%
1Y
33.7%
Gubra
Market Cap: DKK 5.5b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 338.00
7D
-7.2%
1Y
-10.3%
ChemoMetec
Market Cap: DKK 5.2b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 300.20
7D
-2.8%
1Y
-33.4%
Strategic Partners
Market Cap: DKK 25.9m
Does not have significant operations.
STRAP
DKK 620.00
7D
2.0%
1Y
-40.1%